HER2 amplification in Uterine carcinosarcoma after tamoxifen therapy: a case report

Fuqiang ZhengDepartment of Oncology, First Affiliated Hospital of Hunan Normal University (Hunan Provincial People’s Hospital), Changsha, ChinaView further author information

Xiaocai TianDepartment of Oncology, First Affiliated Hospital of Hunan Normal University (Hunan Provincial People’s Hospital), Changsha, ChinaCorrespondence[email protected]
View further author information

"HER2 amplification in Uterine carcinosarcoma after tamoxifen therapy: a case report." Journal of Obstetrics and Gynaecology, 43(1), pp.

Ethical approval

Ethics committee approval was unnecessary due to the nature of the study. Written informed consent was obtained from the patient.

No potential conflict of interest was reported by the author(s).

This work is supported by Ren-Shu Fund of Hunan Provincial People’s Hospital (RS201819).